A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer

Clinical trial NCT00553813 · TERMINATED

Trial details

NCT number: NCT00553813
Sponsor: Cortice Biosciences, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2007-10-01
Primary completion: 2009-09-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.